SandboxAQ integrates drug discovery models into Claude
Original: SandboxAQ brings its drug discovery models to Claude — no PhD in computing required
Why This Matters
Democratizes access to advanced drug discovery AI tools through conversational interface
SandboxAQ partnered with Anthropic to integrate its physics-based AI models into Claude, making drug discovery and materials science tools accessible through natural language without specialized computing infrastructure. The company has raised over $950 million and targets the $50+ trillion quantitative economy.
SandboxAQ, an Alphabet spinout chaired by former Google CEO Eric Schmidt, has integrated its Large Quantitative Models (LQMs) into Anthropic's Claude chatbot. The physics-grounded models can run quantum chemistry calculations and simulate molecular dynamics, helping researchers predict how candidate molecules will behave before lab testing. Previously, users needed their own digital infrastructure to run SandboxAQ's models. The integration allows computational scientists at pharmaceutical and industrial companies to access these sophisticated tools through conversational interface. SandboxAQ has raised more than $950 million and operates multiple business lines including cybersecurity. The company targets the quantitative economy spanning biopharma, financial services, energy, and advanced materials, valued at over $50 trillion.